Courtesy of you.

‘courtesy of you, the entire Kaiser Daily Health Policy Report display, Jearch the archives, or sign up for email delivery at Kaiser Daily Health Policy Report strongly supports imperial network. A free service of The Henry J. Releases. Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

CytoGenix reports positive results of an animal study where mice CYDBA507, CytoGenix avian flu vaccine, protection against lethal challenge immunized with bird flu virus. CYDBA507 is CytoGenix avian influenza vaccine candidate, which built on the CytoGenix synDNA platform and expresses influenza virus type A/H5N1 HA and NA proteins. The ability of CYDBA507 expressing HA and NA proteins in human cells has been confirmed in laboratory studies. Source: CytoGenix.20 percent A surgical ablation of system of be used in a stand-alone method risks are well as reduce patient discomfort and recovery time, is usually only one single night hospital stay that compared to other ablation techniques.. Procedures. CE approval for its Surgical ablate sample with a stabilizing coat.

The surgical ablation tube with stabilizing sheath is a micro – The catheter-based surgical special society INTELLITEM radiofrequency of energy management device powered components are components form consist of the Cardima Surgical Ablation System surgical ablation probe permits creating without gaps gaps by the use of high-frequency and IntelliTemp the ‘operated Communication ‘technology. Probe is small, versatile design has the sole receipt porthole and has a irrigated, inlet and illumination, which help mediation and lesion depth.

The company undertakes not that the forward-looking statements. – Provided Cardima.. PATHFINDE, NAVIPOR, VENAPOR, revelatio INTELLITEM and are registered trademarks of Cardima, Forward-Looking StatementsThis news release may forward-looking statements, including included, forward looking statements non for the use of limited Cardima A surgical ablate systems in the a stand-alone procedure may be reduce risk, and complaints of the patient and recovery time the handled only a single night hospital stay, the system is both to left and right atria , which for a successful treatment of heart rhythm disorders, and the savings for patients, hospitals and doctors, enormous sales potential Europe. These statements involve risks and insecurities.